← All trials
NCT04642924
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 22, 2019
- Primary completion
- Oct 31, 2021
- Completion date
- Oct 31, 2023
- First posted
- Nov 24, 2020
- Last posted
- Nov 24, 2020
- Enrollment
- 203
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Leiden UniversityLead sponsor
- Free University of AmsterdamCollaborator
- Maastricht UniversityCollaborator
- Leiden UniversityCollaborator
- Erasmus University RotterdamCollaborator
- Leiden UniversityReponsible party - principal investigator
- SurgimabCollaborator
- Medical Center HaaglandenCollaborator
- Quest DiagnosticsCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.